• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Nathoo Raffiq

    4/2/25 5:00:11 PM ET
    $CBT
    Major Chemicals
    Industrials
    Get the next $CBT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Nathoo Raffiq

    (Last) (First) (Middle)
    C/O CABOT CORPORATION
    TWO SEAPORT LANE, SUITE 1400

    (Street)
    BOSTON MA 02210

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CABOT CORP [ CBT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    03/31/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Phantom Stock Units (1) 03/31/2025 A 285.663 (2) (2) Common Stock 285.663 $83.14 3,608.8981 D
    Explanation of Responses:
    1. 1 for 1
    2. The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
    By: Mazda Cintron, pursuant to a power of attorney from Raffiq Nathoo 04/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBT

    DatePrice TargetRatingAnalyst
    11/11/2024$105.00Neutral → Underweight
    JP Morgan
    4/18/2024Buy → Hold
    Deutsche Bank
    3/27/2024$104.00Buy
    Mizuho
    1/8/2024$90.00 → $87.00Buy → Neutral
    UBS
    6/6/2023$87.00 → $80.00Overweight → Neutral
    JP Morgan
    3/13/2023$94.00Outperform
    Credit Suisse
    11/16/2022$80.00 → $90.00Hold → Buy
    Deutsche Bank
    1/4/2022$75.00 → $70.00Buy
    UBS
    More analyst ratings

    $CBT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cabot Corporation

      10-Q - CABOT CORP (0000016040) (Filer)

      5/7/25 12:37:39 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Cabot Corporation

      S-8 POS - CABOT CORP (0000016040) (Filer)

      4/7/25 9:33:44 AM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form S-8 POS filed by Cabot Corporation

      S-8 POS - CABOT CORP (0000016040) (Filer)

      4/7/25 9:33:04 AM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cabot downgraded by JP Morgan with a new price target

      JP Morgan downgraded Cabot from Neutral to Underweight and set a new price target of $105.00

      11/11/24 7:37:34 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot downgraded by Deutsche Bank

      Deutsche Bank downgraded Cabot from Buy to Hold

      4/18/24 8:26:59 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Mizuho initiated coverage on Cabot with a new price target

      Mizuho initiated coverage of Cabot with a rating of Buy and set a new price target of $104.00

      3/27/24 8:08:28 AM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cabot Corporation

      SC 13G/A - CABOT CORP (0000016040) (Subject)

      11/12/24 9:50:11 AM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

      SC 13G/A - CABOT CORP (0000016040) (Subject)

      2/12/24 9:53:45 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Cabot Corporation (Amendment)

      SC 13G/A - CABOT CORP (0000016040) (Subject)

      2/9/24 8:50:22 AM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Nathoo Raffiq

      4 - CABOT CORP (0000016040) (Issuer)

      4/2/25 5:00:11 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form 4 filed by Director Enriquez Cabot Juan

      4 - CABOT CORP (0000016040) (Issuer)

      4/2/25 5:00:10 PM ET
      $CBT
      Major Chemicals
      Industrials
    • SEC Form 4 filed by President and CEO Keohane Sean D

      4 - CABOT CORP (0000016040) (Issuer)

      3/18/25 5:30:12 PM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cabot Corp Reports Second Quarter Fiscal 2025 Results

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its second quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.69 and Adjusted EPS of $1.90 which represents a 7% increase in Adjusted EPS compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $131 million; up 1% sequentially; down 12% compared to the same quarter in the prior year  Performance Chemicals segment EBIT of $50 million; up 11% sequentially; up 61% compared to the same quarter in the prior year  Returned $70 million of cash to shareholders in the second quarter through dividends and share repurchases  Increased quarterly dividend by 5% f

      5/5/25 4:30:41 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Board Increases Dividend

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- On Monday, May 5, 2025, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.45 per share, an increase of 5% compared to the current quarterly dividend of $0.43 per share, on all outstanding shares of the Corporation's common stock. The dividend is payable on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. "Today's announcement reflects the Board's confidence in our consistent earnings performance and our ability to generate strong cash flow," said Sean Keohane, President, and Chief Executive Officer of Cabot Corporation. "The dividend increase and the recent share repurchase

      5/5/25 4:26:16 PM ET
      $CBT
      Major Chemicals
      Industrials
    • ITT Nominates Douglas DelGrosso for Election to Board of Directors

      April 8, 2025-- ITT Inc. (NYSE: ITT) today announced the nomination of Douglas DelGrosso for election to its Board of Directors at the company's upcoming 2025 annual meeting of shareholders. Mr. DelGrosso served as president and chief executive officer of Adient plc (NYSE:ADNT), a global engineering and manufacturing company with operations in 29 countries, from October 2018 until his retirement in December 2023. "Over the last several years, the ITT Board has deliberately pursued a refreshment strategy to add seasoned operations executives to our Board with advanced expertise and skills. We are honored at the prospect of having Doug join ITT's Board of Directors and his election will mark

      4/8/25 8:05:00 AM ET
      $ADNT
      $CBT
      $ITT
      Auto Parts:O.E.M.
      Consumer Discretionary
      Major Chemicals
      Industrials

    $CBT
    Leadership Updates

    Live Leadership Updates

    See more
    • Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors

      Cabot Corporation (NYSE:CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a

      7/12/24 4:15:00 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Commended by the International Carbon Black Association for Outstanding Safety Performance

      19 Carbon Black Facilities Across Global Network Receive Safety Awards Cabot Corporation (NYSE:CBT) today announced that 19 of its 20 carbon black manufacturing sites have been recognized by the International Carbon Black Association's (ICBA) Safety Performance Recognition Program. Across the company's global network, 18 of its carbon black facilities received the gold award, the highest recognition available, and one received the bronze award for their outstanding safety performance in 2023. For the industry overall, a total of 35 ICBA member manufacturing facilities were recognized for above average safety performance, with Cabot achieving over half of all awards granted as well as the

      7/10/24 9:00:00 AM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Announces Changes to Board of Directors

      Cabot Corporation (NYSE:CBT) announced today that Michelle Williams, Ph.D., has been elected to its Board of Directors, effective September 13, 2023. She was also appointed a member of the Audit Committee of the Board of Directors, effective September 13, 2023. Prior to her retirement in 2021, Dr. Williams was Global Group President of Altuglas International, a manufacturer of polymethyl methacrylate (PMMA) and a subsidiary of Arkema S.A., a manufacturer of specialty chemicals and advanced materials. Dr. Williams has been a Director of Brady Corporation, a manufacturer and supplier of identification solutions and workplace safety products, since 2019, where she serves as Chair of the Techno

      9/15/23 12:52:00 PM ET
      $CBT
      Major Chemicals
      Industrials

    $CBT
    Financials

    Live finance-specific insights

    See more
    • Cabot Corp Reports Second Quarter Fiscal 2025 Results

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) today announced results for its second quarter of fiscal year 2025. Key Highlights Diluted EPS of $1.69 and Adjusted EPS of $1.90 which represents a 7% increase in Adjusted EPS compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $131 million; up 1% sequentially; down 12% compared to the same quarter in the prior year  Performance Chemicals segment EBIT of $50 million; up 11% sequentially; up 61% compared to the same quarter in the prior year  Returned $70 million of cash to shareholders in the second quarter through dividends and share repurchases  Increased quarterly dividend by 5% f

      5/5/25 4:30:41 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation Board Increases Dividend

      BOSTON, May 05, 2025 (GLOBE NEWSWIRE) -- On Monday, May 5, 2025, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.45 per share, an increase of 5% compared to the current quarterly dividend of $0.43 per share, on all outstanding shares of the Corporation's common stock. The dividend is payable on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. "Today's announcement reflects the Board's confidence in our consistent earnings performance and our ability to generate strong cash flow," said Sean Keohane, President, and Chief Executive Officer of Cabot Corporation. "The dividend increase and the recent share repurchase

      5/5/25 4:26:16 PM ET
      $CBT
      Major Chemicals
      Industrials
    • Cabot Corporation to Announce Second Quarter 2025 Operating Results

      BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the second quarter of fiscal 2025 on Monday, May 5, 2025, after market close. The Company will host a conference call and live webcast to review the second quarter results beginning at 8:00 am (ET) on Tuesday, May 6, 2025. The call will be webcast by Notified and may be accessed at Cabot's website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at https://cabotog.gcs-web.com/. ABOUT CABOT CORPORATIONCabot Corporation (NYSE:CBT)

      4/2/25 7:50:14 AM ET
      $CBT
      Major Chemicals
      Industrials